ELDN
Eledon Pharmaceuticals
$3.57
−$0.01 (−0.28%)Jul 27, 2026
Key metrics
The numbers that frame ELDN today
- Market cap
- $275.56M
- P/E (TTM)
- -3.5
- EV / FCF
- -3.9
- ROIC
- -64.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.35
- 52wk High
- $4.60
Growth
Revenue and earnings trend for ELDN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ELDN
Is Eledon Pharmaceuticals a good buy?
Hold. Eledon Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Eledon Pharmaceuticals is selling at a very high price.
What is the market capitalization of ELDN?
Eledon Pharmaceuticals's market capitalization is $275.56M.
What is the P/E ratio for ELDN stock?
Eledon Pharmaceuticals's current P/E ratio is -3.5.
What is the 52-week high for ELDN stock?
The 52-week high for Eledon Pharmaceuticals is $4.60. The current close of $3.57 is 22.4% below that high.
What is the 52-week low for ELDN stock?
The 52-week low for Eledon Pharmaceuticals is $1.35. The current close of $3.57 is 164.4% above that low.
Does ELDN stock pay dividends?
Eledon Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ELDN?
Eledon Pharmaceuticals's Debt / Equity ratio is 0.01.